Key facts
- This page summarizes Anna Nijdam's Form 4 filing for Pharvaris N.V. (PHVS).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 May 2026, 17:45.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
On April 14, 2026, the reporting person reported an RSU vesting transaction in which 5 additional shares were inadvertently reported as withheld for tax obligations, resulting in an understatement of total beneficial ownership. Following correction of the tax withholding share amount, total beneficial ownership as of April 11, 2026 should have been 48,945 shares rather than 48,940 shares reported previously.
Footnote F2
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $30.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Footnote F3
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Footnote F4
25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.